NCT02605317 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Astarcioglu MA, Sen T, Kilit C, Durmus HI, Gozubuyuk G, Kalcik M, Karakoyun S, Yesin M, Zencirkiran Agus H, Amasyali B
Time-to-reperfusion in STEMI undergoing interhospital transfer using smartphone and WhatsApp messenger. Am J Emerg Med. 2015 Oct;33(10):1382-4. doi: 10.1016/j.ajem.2015.07.029. Epub 2015 Jul 31.
Drake TM, Claireaux HA, Khatri C, Chapman SJ
WhatsApp with patient data transmitted via instant messaging? Am J Surg. 2016 Jan;211(1):300-1. doi: 10.1016/j.amjsurg.2015.04.004. Epub 2015 May 28.
Montag C, Blaszkiewicz K, Sariyska R, Lachmann B, Andone I, Trendafilov B, Eibes M, Markowetz A
Smartphone usage in the 21st century: who is active on WhatsApp? BMC Res Notes. 2015 Aug 4;8:331. doi: 10.1186/s13104-015-1280-z.
Veneroni L, Ferrari A, Acerra S, Massimino M, Clerici CA
[Considerations on the use of WhatsApp in physician-patient communication and relationship]. Recenti Prog Med. 2015 Jul;106(7):331-6. doi: 10.1701/1940.21090. Italian.

Use of whatsApp Messenger (a Messaging Program for Smart Phones) in Communication Between Consulting Physicians and the Emergency Physicians: A Retrospective Observational Study

Details for clinical trial NCT02605317

Clinical trial NCT02605317 - References